Sai Life Sciences Limited — Board Meeting, 14-05-2025: Outcome of Board Meeting

Sai Life Sciences has announced a board meeting outcome approving its audited consolidated financial results for the year ended 31 March 2025. Audited by Deloitte, the results affirm consistent performance across its India, USA, and Germany subsidiaries. The company reported no issues impacting its business continuity. No dividends or fundraising plans were declared. Sai Life continues to demonstrate strong governance and steady progress in the pharma contract research sector.